Literature DB >> 17667118

Nasolacrimal metastasis from heptocellular carcinoma masquerading as dacryocystitis.

Edward J Wladis1, Tamiesha Frempong, Roberta Gausas.   

Abstract

A 69-year-old man presented with a "lump" on his nose, after antibiotic therapy and warm compresses failed to resolve his presumed dacryocystitis. Because this disorder displayed atypical features (no tenderness, no redness, evidence of the greatest expansion of the nasolacrimal system inferior to the lacrimal sac fossa), a neoplastic process was considered. Orbital CT showed a mass obliterating the nasolacrimal system and maxillary sinus. Evaluation of the biopsy specimen revealed metastatic hepatocellular carcinoma of the orbit, making this case the first documentation of this disorder in the nasolacrimal system. Postoperative evaluations revealed an occipital lobe metastasis, and the patient died several months later from his intracranial disease. Clinicians should be aware of this entity, and the presence of atypical features warrants careful evaluation with specific consideration of neoplastic disease.

Entities:  

Mesh:

Year:  2007        PMID: 17667118     DOI: 10.1097/IOP.0b013e3180cac236

Source DB:  PubMed          Journal:  Ophthalmic Plast Reconstr Surg        ISSN: 0740-9303            Impact factor:   1.746


  3 in total

1.  Clinical analysis of 90 cases of malignant lacrimal sac tumor.

Authors:  Xinmao Song; Jie Wang; Shengzi Wang; Weifang Wang; Shuyi Wang; Wenjia Zhu
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-29       Impact factor: 3.117

2.  Transcatheter arterial infusion chemotherapy and embolization for primary lacrimal sac squamous cell carcinoma: A case report.

Authors:  Ming-Hui Sun; Wei-Dong Yi; Ling Shen; Lu Zhou; Jian-Xun Lu
Journal:  World J Clin Cases       Date:  2022-07-26       Impact factor: 1.534

3.  Comparison of Clinical Features and Treatment Outcome in Benign and Malignant Lacrimal Sac Tumors.

Authors:  Che-Yuan Kuo; Chieh-Chih Tsai; Shu-Ching Kao; Wen-Ming Hsu; Catherine Jui-Ling Liu
Journal:  Biomed Res Int       Date:  2020-01-31       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.